HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features.
Tanimura K, Yamada T, Okada K, Nakai K, Horinaka M, Katayama Y, Morimoto K, Ogura Y, Takeda T, Shiotsu S, Ichikawa K, Watanabe S, Morimoto Y, Iwasaku M, Kaneko Y, Uchino J, Taniguchi H, Yoneda K, Matoba S, Sakai T, Uehara H, Yano S, Kusaba T, Katayama R, Takayama K.
Tanimura K, et al. Among authors: kaneko y.
NPJ Precis Oncol. 2022 Jan 18;6(1):5. doi: 10.1038/s41698-021-00250-8.
NPJ Precis Oncol. 2022.
PMID: 35042943
Free PMC article.